Leeford Healthcare Ltd
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Voglimet-GM 2 Tablet SR is a combination of medicines used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet SR
Voglimet-GM 2 Tablet SR belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Voglimet-GM 2 Tablet SR is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Voglimet-GM 2 Tablet SR.
Voglimet-GM 2 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Voglimet-GM 2 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Voglimet-GM 2 Tablet SR is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol, or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Voglimet-GM 2 Tablet SR is a combination medication containing Glimepiride, Metformin, and Voglibose. This medication is used to manage type 2 diabetes mellitus (DM) in adults. It helps regulate blood glucose levels when combined with proper diet and exercise. Glimepiride increases insulin release from the pancreas, Metformin reduces glucose production by the liver and improves insulin sensitivity, and Voglibose inhibits alpha-glucosidase enzymes to lower postprandial glucose levels.
Possible side effects of Voglimet-GM 2 Tablet SR include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection. It is important to report any unexpected or severe side effects to your healthcare professional.
Individuals with known allergies to any component of the medication, those with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis including diabetic ketoacidosis should avoid using this medication. Always consult your healthcare professional before starting treatment.
No, alcohol intake should be avoided when taking Voglimet-GM 2 Tablet SR. It can potentially lower blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
Yes, Voglimet-GM 2 Tablet SR can lead to hypoglycemia (low blood sugar levels). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feelings of anxiety or shakiness. This risk is elevated if you miss meals, drink alcohol, exercise excessively, take other antidiabetic medications simultaneously, or have a history of diabetes.
Store this medication in its original packaging, tightly closed. Follow the specific instructions on the label for proper storage. Do not use expired medication and safely dispose of any unused medicine according to your local regulations, ensuring that it is inaccessible to children, pets, and others.